Chronic Myeloid Leukemia with an e13a3 BCR-ABL Fusion: Benign Course Responsive to Imatinib with an RT-PCR Advisory

American Journal of Hematology

Volumn 75, Issue 2, 2004, Pages 92-95

  Snyder, David S ^a   McMahon, Ross ^a   Cohen, Sandra R ^a   Slovak, Marilyn L ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

CML; RT PCR; Variant BCR ABL

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; HYDROXYUREA; IMATINIB; MESSENGER RNA;

ADULT; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHRONIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DEPRESSION; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; LEUKOCYTOSIS; MALE; NUCLEOTIDE SEQUENCE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; DNA PRIMERS; FUSION PROTEINS, BCR-ABL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; MALE; MUTATION; PIPERAZINES; PYRIMIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TREATMENT OUTCOME;

EID: 0742270483     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.10456     Document Type: Article

References (17)

1. Deininger MWN, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood 2000;96(10):3343-3356.
2. Melo JV. BCR-ABL gene variants. Bailliere's Clin Haematol 1997;10(2):203-222.
3. Iwata S, Mizutani S, Nakazawa S, Yata J. Heterogeneity of the breakpoint in the ABL gene is cases with BCR/ABL transcript lacking ABL exon a2. Leukemia 1994;18(10):1696-1702.
4. van der Plas DC, Soekarman D, van Gent AM, Grosveld G, Hagemeijer A. bcr-abl mRNA lacking abl exon A2 detected by polymerase chain reaction in a chronic myelogenous leukemia patient. Leukemia 1991;5:457-461.
5. Al-Ali H-K, Leiblein S, Kovacs I, Hennig E, Niederwieser D, Deininger MWN. CML with an ela3 BCR-ABL fusion: rare, benign, and a potential diagnostic pitfall. Blood 2002;100(3): 1092-1093.
6. Otazú IB, Rivero MB, Olicio R, Pinto A, Zalcberg I, Seuánez HN. A rare, in-frame BCR-ABL fusion (e13a3) in a patient with an aggressive chronic myeloid leukaemia. Acta Haematol 2002; 108(3):150-153.
7. Bertorelle R, Bonaldi L, Bianchini E, et al. The e19a2 BCR/ABL fusion transcript with additional chromosomal aberrations on a new case of chronic myeloid leukemia (CML) of mild type. Leukemia 2001;15(12):2003-2004.
8. Pane F, Frigeri F, Sindona M, et al. Neutrophilic-chronic myeloid leukemia: a distinct disease with a specific molecular marker (BCR/ABL with C3/A2 junction). Blood 1996;88:2410-2414.
9. Snyder DS, Rossi JJ, Wang J-L, et al. Persistence of bcr-abl gene expression following bone marrow transplantation for chronic myelogenous leukemia in chronic phase, Transplantation 1991; 51:1033-1040.
10. Grosveld G, Verwoerd T, van Agthoven T, et al. The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript. Mol Cell Biol 1986;6(2): 607-616.
11. Sege-Peterson K, Chambers J, Page T, Jones OW, Nyhan WL. Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency. Hum Mol Genet 1992;1:427-432.
12. Nieborowska-Skorska M, Wasik MA, Slupianek A, et al. Signal transducer and activator of transcription (STAT)5 activation by BCR/ABL is dependent on intact Src homology (SH) 3 and SH2 domains of BCR/ABL and is required for leukemogenesis. J Exp Med 1999;189(8):1229-1242.
13. Skorski T, Nieborowska-Skorska M, Wlodarski P, et al. The SH3 domain contributes to BCR/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood 1998;91: 406-418.
14. + chronic myeloid leukemia patients, Blood 2000;95(12):4019-4020.
15. Roumiantsev S, Shah NP, Gorre ME, et al. Clinical resistance to the kinase inhibitor ST1-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Proc Natl Acad Sci USA 2002;99(16):10700-10705.
16. , Corbin AS, Buchdunger E, Pascal F, Druker BJ. Analysis of the structural basis of specificity of inhibition of the Abl kinase by ST1571. J Biol Chem 2002;277(35):32214-32219.
17. , Burmeister T, Maurer J, Aivado M, et al. Quality assurance in RT-PCR-based BCR/ABL diagnostics-results of an interlaboratory test and a standardization approach. Leukemia 2000;14(10): 1850-1856.